Company: G
Filing Date: 2025-11-18
Form Type: 8-K
Source: 0001140361-25-042599
Chunk: 0

Company: Genpact LTD
Filing Date: 2025-11-18
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01.      Entry into a Material Definitive Agreement.  

Notes Offering

On November 18, 2025, Genpact UK Finco plc (“ Genpact UK”) and Genpact USA, Inc. (“ Genpact USA”), indirect wholly owned subsidiaries of Genpact Limited
(“ Genpact”), completed their previously announced underwritten public offering (the “ Notes Offering”) of $350 million aggregate principal amount of their 4.950% Senior Notes due 2030 (the “2030 Notes”). The 2030 Notes are Genpact UK’s and Genpact
USA’s senior unsecured indebtedness and are guaranteed on a senior unsecured basis by Genpact and Genpact Luxembourg S.à r. l. (“ Genpact Luxembourg”). The 2030 Notes were issued pursuant to an indenture dated as of November 18, 2025 (the “ Base
Indenture”) among Genpact UK, Genpact USA, Genpact, Genpact Luxembourg and Computershare Trust Company, National Association, as trustee (the “ Trustee”), and a first supplemental indenture dated as of November 18, 2025 (the “ First Supplemental
Indenture”).

The 2030 Notes have been registered under the Securities Act of 1933, as amended (the “ Securities Act”), pursuant to an effective shelf registration statement
on Form S-3 (File No. 333-291491), as supplemented by the prospectus supplement dated November 13, 2025, filed with the Securities and Exchange Commission under the Securities Act.

In connection with the issuance of the 2030 Notes, Genpact, Genpact UK, Genpact USA and Genpact Luxembourg entered into an Underwriting Agreement dated as of
November 13, 2025 (the “ Underwriting Agreement”), among Genpact UK and Genpact USA, as co-issuers, Genpact and Genpact Luxembourg, as guarantors, and the representatives of the several underwriters named therein (the “ Underwriters”), pursuant to
which Genpact UK and Genpact USA agreed to issue and sell the 2030 Notes to the Underwriters. For a complete description of the terms and conditions of the Underwriting Agreement, please refer to the Underwriting Agreement, which is filed as Exhibit
1.1 hereto, and is incorporated herein by reference.

The 2030